1. Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts
   Aaron Campigotto et al, 2015, Expert Review of Anti-infective Therapy CrossRef
2. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway
   Xiao-Li Li et al, 2016, Journal of Neuroinflammation CrossRef
3. Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
   Yu-Jyun Li et al, 2022, Frontiers in Immunology CrossRef
4. Prospects for the use of statins in antiviral therapy
   R.N. Mustafin, 2023, Clinical Microbiology and Antimicrobial Chemotherapy CrossRef
5. The Roles of Endocytosis and Autophagy at the Cellular Level During Influenza Virus Infection: A Mini-Review
   - Sulpiana et al, 2024, Infection and Drug Resistance CrossRef
6. What treating Ebola means for pandemic influenza
   David S. Fedson, 2018, Journal of Public Health Policy CrossRef
7. Multi-Omics Studies towards Novel Modulators of Influenza A Virus–Host Interaction
   Sandra Söderholm et al, 2016, Viruses CrossRef
8. Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus
   Donna Episcopio et al, 2019, The FASEB Journal CrossRef
9. Contribution of autophagy to antiviral immunity
   Emma Rey-Jurado et al, 2015, FEBS Letters CrossRef
10. Role of cholesterol in anatid herpesvirus 1 infections in vitro
    Manisha Shah et al, 2020, Virus Research CrossRef
11. Immunomodulatory Effects of Statins in the Treatment and Prophylaxis of Influenza Viruses
    null null et al, 2024, Romanian Journal of Military Medicine CrossRef
12. In vitro anti-influenza assessment of anionic compounds ascorbate, acetate and citrate
    Hadiseh Shokouhi Targhi et al, 2022, Virology Journal CrossRef
13. The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections
    Parvaneh Mehrbod et al, 2019, Virulence CrossRef
14. A medium-throughput screen for inhibitors of human metapneumovirus
    Jennifer C Becker et al, 2019, Antiviral Chemistry and Chemotherapy CrossRef
15. Influenza pandemic preparedness
    David S. Fedson, 2019, Indian Journal of Medical Research CrossRef
16. Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics
    Vera Ulyanova et al, 2020, International Journal of Molecular Sciences CrossRef
17. Coronavirus and Cardiometabolic Syndrome
    Jeffrey I. Mechanick et al, 2020, Journal of the American College of Cardiology CrossRef
18. Mechanisms of Action and Efficacy of Statins against Influenza
    Parvaneh Mehrbod et al, 2014, BioMed Research International CrossRef
19. Control of antiviral innate immune response by protein geranylgeranylation
    Shigao Yang et al, 2019, Science Advances CrossRef
20. Association between Statins Administration and Influenza Susceptibility: A Systematic Review and Meta-Analysis of Longitudinal Studies
    Fan Wu et al, 2024, Viruses CrossRef
21. Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection
    Philip T. Lange et al, 2016, Journal of Virology CrossRef
22. Innate Immunity in Viral Encephalitis
    Carol Shoshkes Reiss, 2016, Neurotropic Viral Infections CrossRef
23. The Role of Host Cell Rab GTPases in Influenza a Virus Infections
    Jing Wu et al, 2021, Future Microbiology CrossRef
24. Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
    Puneet Talwar et al, 2019, Current Neuropharmacology CrossRef
25. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
    Punya Shrivastava-Ranjan et al, 2018, mBio CrossRef
26. Statin Therapy and the Risk of Viral Infection: A Retrospective Population-Based Cohort Study
    Biing-Ru Wu et al, 2022, Journal of Clinical Medicine CrossRef
27. Effect of atovastatin treatment on porcine circovirus 2 infection in BALB/c mice
    Xin Yang et al, 2015, Clinical and Experimental Pharmacology and Physiology CrossRef
28. Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-α-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos
    Parvaneh Mehrbod et al, 2019, BMC Complementary and Alternative Medicine CrossRef
29. Autophagy: The multi‐purpose bridge in viral infections and host cells
    Asghar Abdoli et al, 2018, Reviews in Medical Virology CrossRef
30. Fluvastatin delays propagation of viral infection in isolated rat FDB myofibers but does not affect exocytic membrane trafficking
    Mika Nevalainen et al, 2015, Cell Biology International CrossRef
31. Lipophilic statins inhibit Zika virus production in Vero cells
    Erica Españo et al, 2019, Scientific Reports CrossRef
32. The inflammatory response triggered by Influenza virus: a two edged sword
    Luciana P. Tavares et al, 2017, Inflammation Research CrossRef
33. Effect of Statins and Renin–Angiotensin–Aldosterone System Inhibitors on IL-6 Levels in COVID-19 Patients
    Laura Pereckaite et al, 2024, Journal of Clinical Medicine CrossRef
34. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
    Payam Peymani et al, 2021, Translational Medicine Communications CrossRef
35. Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets
    Maria Chiara Proto et al, 2021, Progress in Lipid Research CrossRef
36. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses
    Morvarid Siri et al, 2021, International Journal of Molecular Sciences CrossRef
37. Antiviral strategies against human metapneumovirus: Targeting the fusion protein
    Annelies Van Den Bergh et al, 2022, Antiviral Research CrossRef